IFM Investors’s Roivant Sciences ROIV Stock Holding History

IFM Investors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.71M	Buy	+128,826	New	+$4.67M	0.03%	427

Other funds holding ROIV

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

EWM

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

LWA

Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

IFM Investors's ROIV Position: Q3 2026 in Review

IFM Investors opened a new position in Roivant Sciences (ROIV) in Q3 2026: 128,826 shares worth $4.71M. The stake represents 0.03% of the portfolio and ranks #427 among its holdings.

31 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

IFM Investors held 128,826 shares of Roivant Sciences worth $4.71M as of Q3 2026.
Roivant Sciences was a new IFM Investors position in Q3 2026.
Roivant Sciences made up 0.03% of IFM Investors's portfolio in Q3 2026, its #427 holding.
31 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on IFM Investors's 13F filing for Q3 2026, filed 14 Oct 2026.